XML 55 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Cash Flows (Unaudited) (USD $)
In Thousands, unless otherwise specified
 9 Months Ended
Sep. 25, 2013
Sep. 26, 2012
Cash flows from operating activities:    
Net income $ 20,310 $ 15,829
Adjustments to reconcile net income to cash flows provided by operating activities:    
Depreciation and amortization 15,774 17,174
Operating (gains), losses and other charges, net 1,779 (794)
Amortization of deferred financing costs 376 639
Amortization of debt discount 0 137
Loss on early extinguishment of debt 1,798 8,180
Loss on change in the fair value of interest rate caps 28 62
Deferred income tax expense 8,241 8,988
Share-based compensation 3,434 2,794
Decrease (increase) in assets:    
Receivables 3,519 1,034
Inventories 0 592
Other current assets 2,291 3,885
Other assets (1,399) (2,549)
Increase (decrease) in liabilities:    
Accounts payable (3,461) (4,548)
Accrued salaries and vacations (3,089) 1,246
Accrued taxes 1,823 1,140
Other accrued liabilities (4,015) (5,725)
Other noncurrent liabilities and deferred credits (2,693) (4,061)
Net cash flows provided by operating activities 44,716 44,023
Cash flows from investing activities:    
Capital expenditures (11,819) (7,846)
Acquisition of restaurant (1,622) 0
Proceeds from disposition of property 1,591 14,168
Collections on notes receivable 3,653 1,642
Issuance of notes receivable (1,232) (1,652)
Net cash flows (used in) provided by investing activities (9,429) 6,312
Cash flows from financing activities:    
Net revolver borrowings under new credit agreement 97,000 0
Term loan borrowings under new credit agreement 60,000 190,000
Long-term debt payments (174,820) (215,590)
Proceeds from exercise of stock options 2,077 2,123
Tax withholding on share-based payments (464) (327)
Tax (expense) benefit of stock options exercised (204) 648
Debt transaction costs (366) (1,098)
Deferred financing costs (1,372) (1,809)
Purchase of treasury stock (21,952) (10,442)
Net bank overdrafts (2,421) (3,432)
Net cash flows used in financing activities (42,522) (39,927)
(Decrease) increase in cash and cash equivalents (7,235) 10,408
Cash and cash equivalents at beginning of period 13,565 13,740
Cash and cash equivalents at end of period $ 6,330 $ 24,148